Web Cast of Landmark, Independent Trial Data from Major Breast Cancer Meeting
St. Gallen, Switzerland (ots/PRNewswire)
- Promising News for Breast Cancer Patients
- Web Cast Briefing Available at http://www.ibcsg.org/index.shtm
WHAT: BIG 1-98: First results and implications. A landmark,
independent study found that letrozole, a leading aromatase
inhibitor also known as Femara, demonstrated better efficacy
in reducing the risk of recurrence for breast cancer compared
with the current standard of care, tamoxifen.
Significant findings include:
- Letrozole reduced the risk of breast cancer recurrence by
19% compared with tamoxifen
- Letrozole significantly prolonged disease free survival
compared with tamoxifen
- Letrozole reduced the risk of breast cancer mestasis by 27%
compared with the reduction offered by tamoxifen
This Web cast offers a presentation of the BIG 1-98 trial
results presented at the Primary Therapy of Early Breast
Cancer 9th International Conference in St. Gallen, Switzerland
and an understanding of what the trial results
mean for patients.
BIG 1-98 is an independent Phase III, randomized, double-
blind, controlled clinical trial of more than 8,000
postmenopausal women with early breast cancer
from 27 countries
WHEN: 1:05 pm ET / 7:05 pm. CET, Wednesday, 26 January
WHERE: Click on the following link and view the Web cast data
presentation: http://www.ibcsg.org/index.shtm
WHO: PD Beat Thurlimann, M.D., Scientific Secretary General,
Primary Therapy of Early Breast Cancer, Head of the Senology
Center of Eastern Switzerland, Kantonsspital St. Gallen,
Presentation of the BIG 1-98 Trial Results
CONTACTS: For questions or to arrange an interview with PD Beat
Thurlimann, please contact:
Rum Ekhtiar Nadia Munarini, PhD
Ruder Finn IBCSG
Tel. +1-212-593-5821 Tel. +41-31-389-92-27
ekhtiarr@ruderfinn.com nadia.munarini@ibcsg.orgWeb Site: http://www.ibcsg.org/index.shtm
Contact:
Nadia Munarini, PhD, IBCSG, +41-31-389-92-27, or
nadia.munarini@ibcsg.org; Rum Ekhtiar of Ruder Finn, +1-212-593-5821,
or ekhtiarr@ruderfinn.com, for IBCSG